References
Baek SW, Moon JY, Ryu H, Choi YS, Song IC, Lee HJ, Yun HJ, Kim S, Jo DY (2018) Chronic kidney disease in the BCR-ABL1-negative myeloproliferative neoplasm: a single-center retrospective study. Korean J Intern Med 33(4):790–797
Fukuda Y, Araki M, Yamamoto K, Morishita S, Inano T, Misawa K, Ochiai T, Edahiro Y, Imai M, Yasuda H, Gotoh A, Ohsaka A, Komatsu N (2019) Evidence for prevention of renal dysfunction associated with primary myelofibrosis by cytoreductive therapy. Haematologica 104(11):e506–e509
Strati P, Glass WF, Abdelrahim M, Selamet U, Tchakarov A, Workeneh BT, Verstovsek S, Abudayyeh A (2019) Renal complications of primary myelofibrosis. Leuk Lymphoma 60(2):507–510
Said SM, Leung N, Sethi S et al (2011) Myeloproliferative neoplasms cause glomerulopathy. Kidney Int 80:753–759
Alexander MP, Nasr SH, Kurtin PJ et al (2015) Renal extramedullary hematopoiesis: interstitial and glomerular pathology. Mod Pathol 28:1574–1583
Floege J, Eitner F, Alpers CE (2008) A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19(1):12–23
Imai K, Aoi T, Kitai H, Endo N, Fujino M, Ichida S (2017) A case of perirenal extramedullary hematopoiesis in a patient with primary myelofibrosis. CEN Case Rep 6(2):194–199
Maruyama K, Nakagawa N, Suzuki A, Kabara M, Matsuki M, Shindo M, Iwasaki S, Ogawa Y, Hasebe N (2019) Novel detection of CALR-mutated cells in myeloproliferative neoplasm-related glomerulopathy with interstitial extramedullary hematopoiesis: a case report. Am J Kidney Dis 74(6):844–848
Asou M, Asakawa T, Araki M, Ehara T, Hishima T, Sakamaki H (2021) Primary myelofibrosis-related renal disorders treated with a janus kinase inhibitor. Case Rep Nephrol Dial 11(1):1–9
Acknowledgements
The authors thank Professor Juri Kopolovich for his interpretation of the kidney biopsy.
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Contributions
AB drafted the paper, AR, LS and OB revised it. All authors have revised the drafts and approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare. The authors deny having received any financial support or other benefits from commercial sources for the work reported in this manuscript. The authors also deny any financial interest of any kind which could create a potential conflict of interest or the appearance of a conflict of interest regarding this work.
Ethical approval
This research was performed in accordance with the ethical standards of the institutional research committee and with the declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bnaya, A., Ronson, A., Benjaminov, O. et al. Lesson for the clinical nephrologist: renal involvement in a patient with polycythemia vera. J Nephrol 35, 2123–2126 (2022). https://doi.org/10.1007/s40620-022-01324-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-022-01324-x